--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · NYSE

    LLY — Lilly (Eli)

    Data coverage, completeness and provenance for Lilly (Eli) in the Stock Market API — Health Care · Drug Manufacturers - General.

    NYSE USA S&P 500
    Core-field completeness
    82.4%
    Statement periods
    FY2021–FY2025
    Filings archived
    0
    Price captured
    2026-10-03 23:12 UTC

    Profile

    Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

    Employees: 50,000 · Website: https://www.lilly.com · Profile fields populated: 75%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/LLY/financials.

    Income statement8/10 fields (80.0%)
    Balance sheet14/14 fields (100.0%)
    Cash flow4/6 fields (66.7%)
    Per-share3/4 fields (75.0%)

    Financial statement coverage (USD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2025 2025-12-31 27 sec_edgar
    FY2024 2024-12-31 27 sec_edgar
    FY2023 2023-12-31 27 sec_edgar
    FY2022 2022-12-31 28 sec_edgar
    FY2021 2021-12-31 28 sec_edgar

    Get LLY data via the API

    Every number on this page is one API call away. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/LLY

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/LLY/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/LLY/metrics/summary

    Filings archive

    Report PDFs with LLM-ready markdown conversions where available.

    GET /api/v1/companies/LLY/filings

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/LLY/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/LLY

    Query LLY programmatically

    Free tier — instant API key. Built for AI agents.

    Other NYSE · Health Care companies covered

    Frequently Asked Questions

    What data does the API provide for LLY?
    Company profile, financial statements, computed ratios, price data, filings and news for LLY, via REST endpoints under /api/v1/companies/LLY. Every financial field carries a source tag for provenance.
    How complete is LLY's financial data?
    The anchor reporting period (FY2025) has 82.4% of the 17 core statement fields populated. Primary source: sec_edgar.
    What reporting periods are covered for LLY?
    5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/LLY/financials.
    Where does LLY's data come from?
    Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/LLY/financials, so each value is traceable.